Top Industry News

The latest from CDMOs, CMOs, and suppliers featuring Fujifilm, Thermo Fisher Scientific, Kindeva, Zydus Lifesciences, Becton Dickinson, Lupin/PolyPeptide, Fresenius Kabi/TQ Therapeutics, Bionova Scientific/Syenex, Symbiosis, Kincell, Charles River Laboratories, West Pharmaceuticals,…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring AbbVie/RemeGen, Novartis/SciNeuro Pharmaceuticals, Teva, Bayer, Asahi Kasei and Jazz Pharmaceuticals. For the latest news roundup on small and…

The latest from small and Emerging Pharma companies featuring Caldera, Lyra Therapeutics, Orca Bio and Travere Therapeutics. For news on the large and mid-sized bio/pharmaceutical companies, see Global Briefs. *…

Johnson & Johnson (J&J) became the latest bio/pharmaceutical company this week (January 8, 2026) to reach a deal with the US government over US drug pricing and tariffs amid increasing…

Johnson & Johnson (J&J) has completed its $3.05-billion acquisition of Halda Therapeutics, a clinical-stage bio/pharmaceutical company focused on oral therapies for multiple types of solid tumors, including prostate cancer. The acquisition was announced in November…

BioMarin Pharmaceutical, a Dublin, Ireland-based bio/pharmaceutical company, has agreed to acquire Amicus Therapeutics, a Princeton, New Jersey-based bio/pharmaceutical company specializing in rare diseases, for $4.8 billion.  The acquisition will add two new treatments to BioMarin’s existing portfolio of medicines that…

The latest from CDMOs, CMOs, and suppliers featuring Fujifilm Biosciences/Chitose, Incog BioPharma Solutions, Alcami, Artis BioSolutions/Syngoi Technologies, Gaelic Laboratories/Athlone Laboratories, Halo Pharma, Sharp Sterile Manufacturing and GBI Manufacturing.   Biologics Manufacturing * Fujifilm Biosciences, Chitose Partner for Cell…

A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Amgen, Bayer, Boehringer Ingelheim, Eli Lilly and Company, Johnson & Johnson, Novo Nordisk, Sanofi, Takeda, Alnylam, Argenx, Arthrosi…

The latest from small and Emerging Pharma companies featuring Ambros Therapeutics, Cytokinetics, Day One Biopharmaceuticals/Mersana Therapeutics, Ikarovec/VectorBuilder, Rakuten Medical, and Soley Therapeutics. For news on the large and mid-sized bio/pharmaceutical…

Eli Lilly and Company has announced plans to invest more than $6 billion in a new small-molecule active pharmaceutical ingredient (API) and peptide manufacturing facility in Huntsville, Alabama. The expansion is part of the company’s multi-year $50-billion investments in US…